Shah Rukh Khan should have returned, says Shiv Sena

August 13, 2016

Mumbai, Aug 13: Superstar Shah Rukh Khan, who was detained at an American airport, should have displayed patriotic credentials and returned to India after another "insult" in the US, the Shiv Sena said here today.

1srk

Observing that the "tolerant actor" goes to the US repeatedly, the Sena said if he had decided to return, it would have been a slap on the face of the US. The Sena was reacting to Khan's detention at a US airport, the third time in seven years. The Bollywood actor was detained briefly at the Los Angeles International Airport yesterday.

"This has been a common occurrence with Shah Rukh at most big US airports. Still, this tolerant actor goes to the US repeatedly, only to get insulted," an editorial in Sena mouthpiece Saamana said.

"He should have returned, displaying patriotic credentials, and telling the US that 'I won't step into your country if you are going to insult me in this manner,' the Sena said. "Had he done so, it would have been a slap on the face for America. The US views every Muslim as a terrorist," the Sena said.

The Sena also suggested that the Khans should give direction to the youth of Kashmir which is witnessing rampage. "The Khans of Bollywood should take to Twitter to 'show direction' to misguided youth in Kashmir who are on a rampage," the Sena said.

The editorial also referred to last November's incident when Bollywood actor Aamir Khan said that his wife Kiran Rao wondered whether they should move out of India, as she feared for the safety of their children in a climate of "insecurity".

That was the time when the issue of "rising intolerance" in India was being hotly debated, and when several artists and authors returned government awards to protest "intolerance".

Comments

TRUE INDIAN
 - 
Saturday, 13 Aug 2016

Why modi is visiting us. They also had rejected modis visa.
Shivsena is commenting for the sake of writing. There is no logic.
I think americas treat everyone equally in the airport.

Satyameva jayate
 - 
Saturday, 13 Aug 2016

First time good dialogue from shiv sena.....they started becoming wise after they stopped following modi and BJP blindly......
Sangheez...... security check is for all....but has limits....not how your American father's like....

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
coastaldigest.com web desk
July 1,2020

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 6,2020

Bengaluru, Apr 6: The Covid-19 Task Force aims to conduct 80,000 throat swab and blood tests over the next three weeks here.

According to Task Force Nodal Officer C N Manjunath an order for one lakh anti-body test kits has been placed, and was expected to arrive on April 12.

"From January 20 to March 23, more than 1.2 lakh people arrived at international airports from abroad. Of these, we have kept 37,358 under observation. The Health officials and personnel in fever clinics and hospitals are being trained to conduct the tests. There is no necessity to obtain a clearance to test people with suspected infection. Only laboratories need to get permission to test their blood and throat swab samples."

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
February 26,2020

Mangaluru, Feb 26: The 'Yakshagana' stage in Karnataka is witnessing a curious spectacle with a Muslim woman artiste creating waves with her performances.

Arshiya, the artiste from Vittal in Dakshina Kannada district, is the first woman from the Muslim community to venture into the popular traditional theatre art form.

At one time, women were barred from Yakshagana stages.

A Muslim woman exponent on stage has attracted the attention of 'Yakshagana' lovers in the state.

Arshiya is now getting advanced training in her skills at the Kadali Kala Kendra under Ramesh Bhat here.

Arshiya, who is fond of 'Bannada Vesha' (villain roles), is now known in her stage name 'Tanu Vitla.'

She has already performed various episodes on stage and gained popularity.

Arshiya, currently working in an automobile showroom at Padil, said she was attracted to the art form from a very young age.

The initial enchantment with the art form came as she saw the role of Mahishasura in 'Sri Devi Mahatme Yakshagana Prasanga' (episode) performed near her home town.

She was attracted to all the elements of the art form, which combines music, percussion, dance, dialogues, stage techniques, make-up and costume.

Arshiya said she was also inspired by a teacher in her school at Vittal who trained her for a performance on stage during the school's annual day celebration.

She started performing on local stages at Vittal at the very young age of 10.

Arshiya now performs prominent roles on stage including Mahishasura in Sri Devi Mahatme Prasanga, the role which enamoured her in her childhood.

She also has donned the roles of Nishambhasura, Rakthabeejasura, Srinivas Kalyana, Sudarshanopakyana, Kadamba Kaushike and Shambavi Vijaya.

Her performances at Udupi and Karwar besides Mangaluru have earned her a lot of admirers, who love her 'Asura' roles, thanks to her loud voice.

Arshiya now wants to learn the 'Chende' (percussion instrument), which is an important element in Yakshagana performances.

Arshiya revealed that there was a bit of resistance from her community about her passion for the art form, but she had staunch backing of her family.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.